Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

World thrombectomy devices market is estimated to garner $1,389 million by 2022

Big Market Research
Posted on: 10 Oct 16

“Thrombectomy Devices Market-Opportunity Analysis and Industry Forecast, 2014 - 2022” Order This Report by calling at +1-971-202-1575

Thrombectomy is the surgical removal of blood clot from a blood vessel. Venous thromboembolism (VTE) is a common lethal disease where blood clots within a vein. These clots can travel to arteries or veins in different parts of the body-brain, heart, kidneys, lungs, and limbs. VTE is considered as the cause of heart attack, stroke; however, it can also damage to the body’s organs or even death. VTE results due to various factors, which include combination of hereditary and acquired risk factors, obesity and post-surgery especially hip, knee, or pelvic surgery. It can be found in smoking population and people who take estrogens or birth control pills. VTE is most common in adults (>60 years) but can occur at any age.

The world thrombectomy devices market is estimated to garner $1,389 million by 2022. This is attributed by the increase in the incidence of acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, and pulmonary embolism due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation; rise in the geriatric population. The increase in incidence of cardiovascular diseases; growth in demand for minimally-invasive procedures, and demand for better healthcare infrastructure; and increase in competition, has led to technological advancements and innovations. However, lack of trained professionals and awareness, and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by avoiding sedentary lifestyle and creating awareness among all.

Get Sample Copy of report @

The world thrombectomy devices market is segmented into five categories-technology, type, utility, disease, and geography. Based on the type of technology, the market is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, rheolytic thrombectomy devices. Based on type, the market is divided into automated devices and manual devices. Based on utility, the market is classified into reusable devices and disposable devices. The thrombectomy devices market is segmented into three disease categories, which include peripheral diseases, coronary diseases, and neuro diseases. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players in the thrombectomy devices market. On September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Boston Scientific completed the acquisition of interventional business of Bayer AG on May 2014. This made Boston Scientific the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies.

Purchase a copy of Thrombectomy Devices Market for the price of Single User: Single User :- US $ 4740:


·         The quantitative analysis of the current trends and future estimations from 2014 to 2022 is provided to identify the prevailing opportunities and formulate growth strategies.

·         In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.

·         A detailed analysis based on technology is presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.

·         Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.

·         Competitive intelligence highlights the business practices followed by leading market players across various geographies.


The world thrombectomy devices market segmentation is illustrated as follows:

By Technology

·         Mechanical Thrombectomy Devices

·         Aspiration Thrombectomy Devices

·         Rheolytic Thrombectomy Devices

By Type

·         Automated Devices

·         Manual Devices

By Utility

·         Reusable Devices

·         Disposable Devices

By Diseases

·         Peripheral Diseases

·         Coronary Diseases

·         Neural Diseases

By Geography

·         North America

o    U.S.

o    Canada

o    Mexico

·         Europe

o    U.K.

o    Germany

o    France

o    Spain

o    Italy

o    Others

·         Asia-Pacific

o    China

o    Japan

o    India

o    Others

·         LAMEA

o    Brazil

o    Saudi Arabia

o    South Africa

o    Others

Company profiles

·         Boston Scientific Corporation

·         Medtronic Plc

·         Teleflex Incorporated

·         Penumbra Inc.

·         The Spectranetics Corporation

·         AngioDynamics, Inc.

·         Terumo Corporation

·         Johnson and Johnson, Inc.

·         Stryker Corporation

·         Vascular Solutions, Inc.

Get Complete Report @

Contact us:

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

Direct: + 1-503-894-6022

Toll Free: + 1-800-910-6452

Fax: +1 (855) 550–5975






Editor's Details

Pranjal Mehta

Last updated on: 10/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.